Two powerful antibodies neutralizing more than 90 percent of known HIV virus strains have been discovered by US researchers.
NIH-led scientists discovered the antibodies known as VRCO1 and VRCO2 that prevent most HIV strains from infecting human cells. The find is a potential breakthrough for advancing HIV vaccine design, and antibody therapy for other diseases.
AIDS/HIV - Clinical Features
Encyclopedia section of medindia gives general info about HIV Clinical Features
Advertisement
The authors, whose work is published in the July 9 issue of Science, also were able to demonstrate how one of these disease-fighting proteins gets the job done.
"The discovery of these exceptionally broadly neutralizing antibodies to HIV and the structural analysis that explains how they work are exciting advances that will accelerate our efforts to find a preventive HIV vaccine for global use," said Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health.
![AIDS/HIV - Lab Tests and FAQs]( "AIDS/HIV - Lab Tests and FAQs")
"In addition, the technique the teams used to find the new antibodies represents a novel strategy that could be applied to vaccine design for many other infectious diseases," Fauci stressed in a statement.
The team of virologists found that the two antibodies were produced naturally and found in the blood of HIV-positive people.
They were able to isolate these antibodies using a new molecular device they developed. It zeroes in on specific cells that make antibodies against HIV. The device is an HIV protein scientists modified to react only with antibodies specific to the site where the virus binds to cells it infects.
Leading two research teams were NIAID scientists Peter Kwong, Ph.D., John Mascola, MD, and Gary Nabel, MD, Ph.D.
"We have used our knowledge of the structure of a virus -- in this case, the outer surface of HIV -- to refine molecular tools that pinpoint the vulnerable spot on the virus and guide us to antibodies that attach to this spot, blocking the virus from infecting cells," explained Nabel.
Mascola added that: "the antibodies attach to a virtually unchanging part of the virus, and this explains why they can neutralize such an extraordinary range of HIV strains."
Source: AFP
Advertisement
"In addition, the technique the teams used to find the new antibodies represents a novel strategy that could be applied to vaccine design for many other infectious diseases," Fauci stressed in a statement.
The team of virologists found that the two antibodies were produced naturally and found in the blood of HIV-positive people.
They were able to isolate these antibodies using a new molecular device they developed. It zeroes in on specific cells that make antibodies against HIV. The device is an HIV protein scientists modified to react only with antibodies specific to the site where the virus binds to cells it infects.
Leading two research teams were NIAID scientists Peter Kwong, Ph.D., John Mascola, MD, and Gary Nabel, MD, Ph.D.
"We have used our knowledge of the structure of a virus -- in this case, the outer surface of HIV -- to refine molecular tools that pinpoint the vulnerable spot on the virus and guide us to antibodies that attach to this spot, blocking the virus from infecting cells," explained Nabel.
Mascola added that: "the antibodies attach to a virtually unchanging part of the virus, and this explains why they can neutralize such an extraordinary range of HIV strains."
Source: AFP
AIDS / HIV - Treatment
Encyclopedia section of medindia explains in brief about the treatment for AIDS/HIV
Advertisement
 Quiz on HIV / AIDSStatistics tell us that the world HIV+ population has risen drastically from 8 million in 1990 to a whopping 33 million in 2007! Even more alarming is the fact that young people (below the age of 25) account for half of these infections! This is adequate proof for the lack of awareness among the general public even in these modern times. So take our quiz and brush up on the essential facts of HIV/ | Advertisement
|
Advertisement
Latest Research News
Limb savage procedure benefits patients with severe vascular disease who are at risk for amputation of their limbs.
Does omega-3 help Alzheimer's patients? A new form of omega-3 helped restore specific markers of eye health in mice bred with aspects of early-onset Alzheimer's disease.
Drugs used to inhibit the physiological responses for allergic reactions lessen osteoarthritis risk, revealed research.
The International Space Station will be used to carry out experiments seeking to improve understanding of incurable child brain tumors and the muscle aging process.
How many people in the UK have misophonia? In a representative sample study, most people had at least some irritation upon hearing trigger sounds.